PORTA, CAMILLO: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

Jordi Bruix, Jean-Luc Raoul, Morris Sherman, Vincenzo Mazzaferro, Luigi Bolondi, Antonio Craxi, Peter R. Galle, Armando Santoro, Michel Beaugrand, Angelo Sangiovanni, Camillo Porta, Guido Gerken, Jorg

Journal:

Journal of Hepatology

Year:

2012

Language:

english

File:

PDF, 934 KB

english, 2012

2

A new patient-focused approach to the treatment of metastatic renal cell carcinoma: establishing customized treatment options

Joaquim Bellmunt, Tim Eisen, Cezary Szczylik, Peter Mulders, Camillo Porta

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 567 KB

english, 2011

3

Cost-effectiveness of Pazopanib Versus Sunitinib as First-line Treatment for Locally Advanced or Metastatic Renal Cell Carcinoma from an Italian National Health Service Perspective

Capri, Stefano, Porta, Camillo, Delea, Thomas E.

Journal:

Clinical Therapeutics

Year:

2017

Language:

english

File:

PDF, 498 KB

english, 2017

4

Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs

Fogli, Stefano, Porta, Camillo, Del Re, Marzia, Crucitta, Stefania, Gianfilippo, Giulia, Danesi, Romano, Rini, Brian I., Schmidinger, Manuela

Journal:

Cancer Treatment Reviews

Year:

2020

Language:

english

File:

PDF, 1007 KB

english, 2020

5

Application of âomicsâ sciences to the prediction of bone metastases from breast cancer: State of the art

Gentile, Marica, Centonza, Antonella, Lovero, Domenica, Palmirotta, Raffaele, Porta, Camillo, Silvestris, Franco, D'Oronzo, Stella

Journal:

Journal of Bone Oncology

Year:

2021

File:

PDF, 104 KB

2021

6

Is immunotherapy re-entering the kidney cancer arena from the back door? Considerations from the Phase I/II study of siltuximab

Porta, Camillo, Pedrazzoli, Paolo, Paglino, Chiara

Journal:

Year:

2011

Language:

english

File:

PDF, 343 KB

english, 2011

7

Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines

Frascà, Giovanni M., Brigante, Fabiana, Volpe, Alessandro, Cosmai, Laura, Gallieni, Maurizio, Porta, Camillo

Journal:

Journal of Nephrology

Year:

2018

Language:

english

File:

PDF, 1.30 MB

english, 2018

8

Efficacy of Nivolumab plus Ipilimumab According to Number of IMDC Risk Factors in CheckMate 214

Escudier, Bernard, Motzer, Robert J., Tannir, Nizar M., Porta, Camillo, Tomita, Yoshihiko, Maurer, Matthew A., McHenry, M. Brent, Rini, Brian I.

Journal:

European Urology

Year:

2019

Language:

english

File:

PDF, 993 KB

english, 2019

9

Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors

Gibellini, Lara, De Biasi, Sara, Porta, Camillo, Lo Tartaro, Domenico, Depenni, Roberta, Pellacani, Giovanni, Sabbatini, Roberto, Cossarizza, Andrea

Journal:

Frontiers in Immunology

Year:

2020

Language:

english

File:

PDF, 892 KB

english, 2020

10

An evaluation of UGN-101, a sustained-release hydrogel polymer-based formulation containing mitomycin-C, for the treatment of upper urothelial carcinomas

Porta, Camillo, Giannatempo, Patrizia, Rizzo, Mimma, Lucarelli, Giuseppe, Ditonno, Pasquale, Battaglia, Michele

Journal:

Expert Opinion on Pharmacotherapy

Year:

2020

File:

PDF, 559 KB

2020

11

KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, andÂ managing kidney cancer

Porta, Camillo, Bamias, Aristotelis, Danesh, Farhad R., DÄbska-ÅlizieÅ, Alicja, Gallieni, Maurizio, Gertz, Morie A., Kielstein, Jan T., Tesarova, Petra, Wong, Germaine, Cheung, Michael, Wheeler, Da

Journal:

Kidney International

Year:

2020

File:

PDF, 1.36 MB

2020

12

Thrombotic Thrombocytopenic Purpura and Relapes: Why do case series differ?

Camillo Porta, Riccardo Centurioni, Luigi Gugliotta, Enrico Bobbio-Phllavicini, Atto Billio

Journal:

American Journal of Hematology

Year:

1996

Language:

english

File:

PDF, 192 KB

english, 1996

13

Utility of embolization or chemoembolization as second-line treatment in patients with advanced or recurrent colorectal carcinoma

Camillo Porta, Mauro Moroni, Giuseppe Nastasi, Enrico Bobbio-Pallavicini, Giancarlo Barazzoni, Scott Wadler, Curtis W. Bakal, Jacob Cynamon, Peter H. Wiernik

Journal:

Year:

1995

Language:

english

File:

PDF, 344 KB

english, 1995

14

Interleukin-2 induces cell cycle perturbations leading to cell growth inhibition and death in malignant mesothelioma cells in vitro

Camillo Porta, Marco Danova, Anna Maria Orengo, Silvano Ferrini, Mauro Moroni, Alessia Gaggero, Roberta Libener, Pier Giorgio Betta, Silvia Ferrari, Antonio Procopio, Luigi Strizzi, Luciano Mutti

Journal:

Journal of Cellular Physiology

Year:

2000

Language:

english

File:

PDF, 218 KB

english, 2000

15

High-dose human immunoglobulins in thrombotic thrombocytopenic purpura

Camillo Porta, Enrico Bobbio-Pallavicini

Journal:

American Journal of Hematology

Year:

1994

Language:

english

File:

PDF, 232 KB

english, 1994

16

Allopurinal mouthwashes in methotraxate-induced stomatitis

Carlomaurizio Montecucco, Roberto Caporali, Silvia Rossi, Camillo Porta

Journal:

Arthritis & Rheumatism

Year:

1994

Language:

english

File:

PDF, 175 KB

english, 1994

17

Gemcitabine and oxaliplatin in the treatment of patients with immunotherapy-resistant advanced renal cell carcinoma : Final results of a single-institution Phase II study

Camillo Porta, Matteo Zimatore, Ilaria Imarisio, Anna Natalizi, Andrea Sartore-Bianchi, Marco Danova, Alberto Riccardi

Journal:

Year:

2004

Language:

english

File:

PDF, 171 KB

english, 2004

18

Cisplatin and gemcitabine with either vinorelbine or paclitaxel in the treatment of carcinomas of unknown primary site : Results of an Italian Multicenter, randomized, phase II study

Sergio Palmeri, Vito Lorusso, Laura Palmeri, Marina Vaglica, Camillo Porta, Rolando Nortilli, Francesco Ferraú, Giuseppe Comella, Bruno Massidda, Marco Danova

Journal:

Year:

2006

Language:

english

File:

PDF, 153 KB

english, 2006

19

Phase 3 trial of everolimus for metastatic renal cell carcinoma : Final results and analysis of prognostic factors

Robert J. Motzer, Bernard Escudier, Stephane Oudard, Thomas E. Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A. Thompson, Robert A. Figlin, Norbert Hollaender, Andrea Kay, Alain Ravaud

Journal:

Year:

2010

Language:

english

File:

PDF, 426 KB

english, 2010

20

Sunitinib in metastatic renal cell carcinoma patients with brain metastases

Martin E. Gore, Subramanian Hariharan, Camillo Porta, Sergio Bracarda, Robert Hawkins, Georg A. Bjarnason, Stéphane Oudard, Se-Hoon Lee, Giacomo Carteni, Alejandra Nieto, Jinyu Yuan, Cezary Szczylik

Journal:

Year:

2011

Language:

english

File:

PDF, 279 KB

english, 2011

21

Effect of different platelet agonists on intracellular free CA++ concentrations in human tumor cells: Possible role in tumor growth

Anna Saporiti, Alessandra Brocchieri, Camillo Porta, Mauro Moroni, Guido Grignani

Journal:

International Journal of Cancer

Year:

1995

Language:

english

File:

PDF, 687 KB

english, 1995

22

Nephrectomy as a component of systemic treatment for renal cell carcinoma patients

Giuseppe Nastasi, Camillo Porta, Mauro Moroni, Enrico Bobbio-Pallavicini, Giuseppe Santagati, Carlo Santagati, Mario Alessiani

Journal:

Journal of Surgical Oncology

Year:

1994

Language:

english

File:

PDF, 164 KB

english, 1994

23

EOSINOPHILS AND SERUM EOSINOPHILIC CATIONIC PROTEINS IN INTERLEUKIN-2-BASED IMMUNOTHERAPY FOR CANCER

Camillo Porta, Mauro Moroni, Mara De Amici

Journal:

British Journal of Haematology

Year:

1998

Language:

english

File:

PDF, 865 KB

english, 1998

24

‘Tunel’ evidence of reduced bone marrow cells apoptosis in a refractory anaemia patient treated with amifostine

Mauro Moroni, Camillo Porta, Rosangela Invernizzi, Alessandro Inzoli, Francesca Bobbio-Pallavicini, Enrico Bobbio-Pallavinci

Journal:

British Journal of Haematology

Year:

1999

Language:

english

File:

PDF, 604 KB

english, 1999

25

Safety and treatment patterns of multikinase inhibitors in patients with metastatic renal cell carcinoma at a tertiary oncology center in Italy

Camillo Porta, Chiara Paglino, Ilaria Imarisio, Cinzia Canipari, Kristina Chen, Maureen Neary, Mei Sheng Duh

Journal:

Year:

2011

Language:

english

File:

PDF, 189 KB

english, 2011

26

Lack of dendritic cell mobilization into the peripheral blood of cancer patients following standard- or high-dose chemotherapy plus granulocyte-colony stimulating factor

Silvia Ferrari, Bianca Rovati, Camillo Porta, Paolo Emilio Alessandrino, Alessandro Bertolini, Elena Collovà, Alberto Riccardi, Marco Danova

Journal:

Cancer Immunology, Immunotherapy

Year:

2003

Language:

english

File:

PDF, 343 KB

english, 2003

27

Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer

Rodolfo Passalacqua, Carlo Buzio, Sebastiano Buti, Camillo Porta, Roberto Labianca, Debora Pezzuolo, Roberta Camisa, Roberto Sabbatini, Luigi Benecchi, Caterina Messina, Rita Cengarle, Augusto Vaglio,

Journal:

Cancer Immunology, Immunotherapy

Year:

2010

Language:

english

File:

PDF, 284 KB

english, 2010

28

Negative results of an Italian Group for Mesothelioma (G.I.Me.) pilot study of single-agent imatinib mesylate in malignant pleural mesothelioma

Camillo Porta, Luciano Mutti, Gianfranco Tassi

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2007

Language:

english

File:

PDF, 147 KB

english, 2007

29

Sequential intrahepatic and systemic fluoropyrimidine-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study

Camillo Porta, Marco Danova, Salvatore Accurso, Carmine Tinelli, Margherita Girino, Alberto Riccardi, Sergio Palmeri

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2001

Language:

english

File:

PDF, 137 KB

english, 2001

30

In vitro antioxidant properties of amifostine (WR-2721, Ethyol)

Fulvio Marzatico, Camillo Porta, Mauro Moroni, Laura Bertorelli, Elena Borasio, Nicoletta Finotti, Orietta Pansarasa, Laura Castagna

Journal:

Cancer Chemotherapy and Pharmacology

Year:

2000

Language:

english

File:

PDF, 199 KB

english, 2000

31

Possible efficacy of allopurinol vaginal washings in the treatment of chemotherapy-induced vaginitis

M. Moroni, Camillo Porta

Journal:

Cancer Chemotherapy and Pharmacology

Year:

1997

Language:

english

File:

PDF, 82 KB

english, 1997

32

Oncology reviews: reasons for a new oncology journal

Journal:

Oncology Reviews

Year:

2007

Language:

english

File:

PDF, 38 KB

english, 2007

33

How to predict the development of hepatocellular carcinoma in cirrhotic patients. Despite recent advances, the search continues

Camillo Porta, Mara De Amici

Journal:

Oncology Reviews

Year:

2008

Language:

english

File:

PDF, 46 KB

english, 2008

34

ASCO 2007: “Translating Research into Practice”. Report from the 34thannual meeting of the American Society of Clinical Oncology

Journal:

Oncology Reviews

Year:

2007

Language:

english

File:

PDF, 75 KB

english, 2007

35

To fast or not to fast? How food could impact on the absorption of kinase inhibitors and its economical value

Journal:

Oncology Reviews

Year:

2007

Language:

english

File:

PDF, 50 KB

english, 2007

36

Allogeneic transplantation following non-myeloablative conditioning in renal carcinoma. New evidence of the immune mechanisms responsible for the activity of this form of immunotherapy and the pathogenetic role of endogenous retroviruses

Journal:

Oncology Reviews

Year:

2008

Language:

english

File:

PDF, 50 KB

english, 2008

37

The role of Lyn kinase in the development of imatinib resistance in chronic myelogenous leukemia

Camillo Porta, Federica Tagliani

Journal:

Oncology Reviews

Year:

2008

Language:

english

File:

PDF, 28 KB

english, 2008

38

Hepatitis b virus genotype and mutants and the risk of hepatocellular carcinoma

Journal:

Oncology Reviews

Year:

2008

Language:

english

File:

PDF, 36 KB

english, 2008

39

Is more better than less? Caveats from bevacizumab and cetuximab combination in colorectal cancer

Journal:

Oncology Reviews

Year:

2009

Language:

english

File:

PDF, 83 KB

english, 2009

40

Sequencing or not sequencing multikinase inhibitors in kidney cancer: this is the dilemma

Chiara Paglino, Camillo Porta

Journal:

Oncology Reviews

Year:

2010

Language:

english

File:

PDF, 190 KB

english, 2010

41

Sorafenib tosylate for advanced kidney cancer: lucky loser and magic box at the same time

Journal:

Oncology Reviews

Year:

2011

Language:

english

File:

PDF, 89 KB

english, 2011

42

Determination of free and total (free plus protein-bound) melatonin in plasma and cerebrospinal fluid by high-performance liquid chromatography with fluorescence detection

Vittoria Rizzo, Camillo Porta, Mauro Moroni, Enrico Scoglio, Remigio Moratti

Journal:

Journal of Chromatography B

Year:

2002

Language:

english

File:

PDF, 142 KB

english, 2002

43

TREATMENT OF METASTATIC RENAL CARCINOMA PATIENTS WITH THE COMBINATION OF GEMCITABINE, CAPECITABINE AND BEVACIZUMAB AT A TERTIARY CANCER CENTRE

Camillo Porta, Chiara Paglino

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 96 KB

english, 2011

44

Sequential use of sorafenib and sunitinib in advanced renal-cell carcinoma (RCC): an Italian multicentre retrospective analysis of 189 patient cases

Camillo Porta, Giuseppe Procopio, Giacomo Cartenì, Roberto Sabbatini, Alessandra Bearz, Isabella Chiappino, Enzo Maria Ruggeri, Giovanni Lo Re, Riccardo Ricotta, Fable Zustovich, Lorenza Landi, Anna C

Journal:

BJU International

Year:

2011

Language:

english

File:

PDF, 412 KB

english, 2011

45

Combination or sequencing strategies to improve the outcome of metastatic renal cell carcinoma patients: A critical review

Camillo Porta, Cezary Szczylik, Bernard Escudier

Journal:

Critical Reviews in Oncology/Hematology

Year:

2012

Language:

english

File:

PDF, 283 KB

english, 2012

46

Re: Damien Pouessel, Stéphane Culine. High Frequency of Intracerebral Hemorrhage in Metastatic Renal Carcinoma Patients with Brain Metastases Treated with Tyrosine Kinase Inhibitors Targeting the Vascular Endothelial Growth Factor Receptor. Eur Urol 2008;53:376–81

Camillo Porta, Ilaria Imarisio, Chiara Paglino

Journal:

European Urology

Year:

2008

Language:

english

File:

PDF, 42 KB

english, 2008

47

Toxicities of Targeted Therapy and Their Management in Kidney Cancer

Giuseppe Di Lorenzo, Camillo Porta, Joaquim Bellmunt, Cora Sternberg, Ziya Kirkali, Michael Staehler, Steven Joniau, Francesco Montorsi, Carlo Buonerba

Journal:

European Urology

Year:

2011

Language:

english

File:

PDF, 433 KB

english, 2011

48

Entropy Increases in Kidney Cancer Treatment, but a Bit of Simplicity May Emerge From Chaos

Journal:

European Urology

Year:

2011

Language:

english

File:

PDF, 77 KB

english, 2011

49

Efficacy and Safety of Everolimus in Elderly Patients With Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial

Camillo Porta, Emiliano Calvo, Miguel A. Climent, Ulka Vaishampayan, Susanne Osanto, Alain Ravaud, Sergio Bracarda, Thomas E. Hutson, Bernard Escudier, Viktor Grünwald, Dennis Kim, Ashok Panneerselvam

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 424 KB

english, 2012

50

Reply to Giuseppe Procopio, Elena Verzoni and Filippo De Braud's Letter to the Editor re: Camillo Porta, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and Safety of Everolimus in Elderly Patients with Metastatic Renal Cell Carcinoma: An Exploratory Analysis of the Outcomes of Elderly Patients in the RECORD-1 Trial. Eur Urol 2012;61:826–33

Camillo Porta, Robert J. Motzer

Journal:

European Urology

Year:

2012

Language:

english

File:

PDF, 75 KB

english, 2012

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски